PQQ for Increased Energy Production
Energy claims follow from the mitochondrial hypothesis rather than demonstrated outcomes.
Overview
Verdict
How It Works
Dosing & Protocol
Typical dose
- Recommended dose
- Studied at 20 mg/day; no reliable improvement in energy or fatigue has been demonstrated
- Expected timeframe
- Not established
Protocol
- form
- PQQ disodium salt
- duration
- Trials ran 8-12 weeks
- co factor
- Evidence is insufficient. The energy claims for PQQ derive from preclinical work showing it upregulates PGC-1alpha and mitochondrial biogenesis in cells and rodents, plus a small Japanese study reporting improvements in self-rated fatigue, sleep quality and vigour at 20 mg/day. That study was small, poorly described methodologically and has not been independently replicated in an adequately powered trial. No human study has measured ATP production, resting metabolic rate, exercise capacity or objective fatigue endpoints after PQQ supplementation. Subjective energy is also among the most placebo-responsive outcomes in supplement research, which makes small unblinded findings particularly unreliable.
- titration
- Not applicable - no dose has been shown to increase energy production in people
- starting dose
- Not established. Human trials used 20 mg/day PQQ disodium salt, occasionally 40 mg/day
Evidence
What the studies say
No studies are yet linked to both PQQ and Increased Energy Production.
Safety
Caveats
Persistent fatigue deserves a diagnosis rather than a supplement. Common and treatable causes include iron deficiency with or without anaemia, hypothyroidism, sleep apnoea, depression, diabetes, coeliac disease, vitamin B12 or D deficiency, chronic kidney disease, and medication effects from beta-blockers, antihistamines, opioids and antidepressants. Fatigue with weight loss, night sweats, breathlessness, lymph node swelling or bleeding needs prompt medical assessment. Sleep quantity and regularity, physical activity and alcohol reduction produce far more change than any energy supplement. Safety of PQQ: the human evidence base is small and short, so long-term safety is unknown - reported side effects at 20-40 mg/day include headache, fatigue and sleep disturbance, which is a notable irony for an energy product. No upper intake level has been established for humans, and a rodent study found kidney effects at very high doses, so do not exceed the 20 mg/day studied. Avoid in pregnancy and breastfeeding, as no safety data exist. Drug interactions are undocumented rather than excluded.
Less likely to help if
Medical Disclaimer
The information provided on this website is for educational and informational purposes only and is not intended as a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition or before starting any supplement regimen.
Individual results may vary. The statements on this website have not been evaluated by the Food and Drug Administration. Products and information are not intended to diagnose, treat, cure, or prevent any disease.